Murtoniemi, Katja http://orcid.org/0000-0001-8971-2984
Villa, Pia M.
Matomäki, Jaakko
Keikkala, Elina
Vuorela, Piia
Hämäläinen, Esa
Kajantie, Eero
Pesonen, Anu-Katriina
Räikkönen, Katri
Taipale, Pekka
Stenman, Ulf-Håkan
Laivuori, Hannele
Funding for this research was provided by:
Finska Läkaresällskapet
Päivikki ja Sakari Sohlbergin Säätiö
Foundation of EVO research funding (A special Finnish state subsidy for health science research)
Foundation of EVO research funding
Suomen Akatemia (FI)
Suomen Akatemia
Signe ja Ane Gyllenbergin Säätiö
Sigrid Juséliuksen Säätiö
University of Helsinki Research Funds
Suomen Lääketieteen Säätiö
Jane ja Aatos Erkon Säätiö
Article History
Received: 19 April 2017
Accepted: 19 June 2018
First Online: 3 July 2018
Ethics approval and consent to participate
: An Ethics Committee of the Helsinki and Uusimaa Hospital District approved the study and written informed consent was obtained from all participants.
: Not applicable.
: Consulting fees from Roche Diagnostics (Villa). Finox Biotech Nordics AB, unconditional support for the Meeting of the Nordic Expert Group (Laivuori).
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.